XML 14 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statement of Cash Flows - EUR (€)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Cash flows from operating activities        
Net result € (13,189,000) € (12,191,000) € (33,386,000) € (38,167,000)
Adjustments for:        
Depreciation 651,000 506,000 1,703,000 1,543,000
Share-based compensation 1,676,000 1,226,000 6,348,000 4,614,000
Other income     (8,423,000)  
Financial income and expenses 1,863,000 (1,375,000) 2,024,000 (1,339,000)
Results related to associates 84,000 119,000 270,000 (579,000)
Results related to financial liabilities measured at fair value through profit or loss 305,000   305,000  
Net foreign exchange gain / (loss) (255,000) 148,000 (134,000) 122,000
Changes in working capital (246,000) 2,718,000 (3,354,000) 1,744,000
Cash used in operations (9,111,000) (8,849,000) (34,647,000) (32,062,000)
Corporate income tax paid (157,000)   (168,000) (64,000)
Interest received 27,000 90,000 118,000 176,000
Interest paid (569,000) (13,000) (607,000) (64,000)
Net cash used in operating activities (9,810,000) (8,772,000) (35,304,000) (32,014,000)
Cash flow from investing activities        
Purchases of property, plant and equipment (264,000) (32,000) (806,000) (341,000)
Net cash used in investing activities (264,000) (32,000) (806,000) (341,000)
Cash flow from financing activities        
Proceeds from exercise of share options 12,000 2,000 724,000 166,000
Proceeds from borrowings     579,000  
Proceeds from convertible loans 13,477,000   13,542,000 690,000
Repayment of lease liability (235,000) (290,000) (542,000) (861,000)
Net cash generated by/(used in) financing activities 13,254,000 (288,000) 14,303,000 (5,000)
Net increase/(decrease) in cash and cash equivalents 3,180,000 (9,092,000) (21,807,000) (32,360,000)
Currency effect cash and cash equivalents (1,474,000) 1,420,000 (1,296,000) 1,572,000
Cash and cash equivalents, at beginning of the period 87,141,000 82,464,000 111,950,000 105,580,000
Cash and cash equivalents at the end of the period € 88,847,000 € 74,792,000 € 88,847,000 € 74,792,000